6354 studies found for:    breast,cancer,treatment
Show Display Options
Rank Status Study
1 Completed
Has Results
Understanding Shared Psychobiological Pathways
Condition: Breast Neoplasms
Interventions: Behavioral: Education;   Behavioral: Peer support
2 Recruiting A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Condition: Vaginal Atrophy
Interventions: Drug: estriol;   Drug: Placebo
3 Completed Stress Management in Breast Cancer Patients
Conditions: Breast Cancer;   Stress
Intervention: Behavioral: Stress management, in two steps
4 Recruiting Hula, a Physical Activity Intervention for Female-Cancer Survivors
Conditions: Physical Activity;   Breast Cancer;   Cervical Cancer;   Ovarian Cancer;   Endometrial Cancer
Intervention: Behavioral: Hula
5 Active, not recruiting Cognitive Changes Associated With Breast Cancer Treatment
Conditions: Breast Cancer;   Cognitive Side Effects of Cancer Treatments;   Stage I, II and III A Breast Cancer
Intervention: Behavioral: Questionnaires, MRI, Comet assay and Cell senescence
6 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate
7 Completed Predictive Model of Therapy Outcomes in Breast Cancer Patients
Condition: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
Intervention:
8 Active, not recruiting Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Conditions: Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Positive;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Aromatase Inhibition Therapy;   Drug: Carboplatin;   Other: Cytology Specimen Collection Procedure;   Drug: Docetaxel;   Drug: Goserelin Acetate;   Other: Laboratory Biomarker Analysis;   Biological: Pertuzumab;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery;   Biological: Trastuzumab;   Radiation: Whole Breast Irradiation
9 Active, not recruiting Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation
Condition: Cancer of the Breast
Interventions: Procedure: Surgery for breast cancer;   Other: No Loco-regional treatment
10 Completed Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors
Conditions: Breast Cancer;   Cancer Survivor;   Fatigue;   Long-term Effects Secondary to Cancer Therapy in Adults;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Behavioral: exercise intervention;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: survey administration;   Procedure: assessment of therapy complications;   Procedure: fatigue assessment and management;   Procedure: management of therapy complications;   Procedure: psychosocial assessment and care
11 Active, not recruiting Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Multi-Beam Intensity-Modulated Radiation Therapy
12 Completed
Has Results
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Conditions: Breast Cancer;   Dermatologic Complications;   Radiation Toxicity;   Skin Reactions Secondary to Radiation Therapy
Interventions: Drug: mometasone furoate;   Other: placebo
13 Not yet recruiting Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
Condition: Breast Cancer
Intervention: Radiation: Adjuvant Hypofractionated Radiation
14 Recruiting Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Condition: HR+ HER2- Postmenopausal Advanced Breast Cancer
Interventions: Drug: Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant;   Drug: Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
15 Recruiting PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Condition: Breast Cancer
Interventions: Drug: Neoadjuvant tamoxifen + goserelin (premenopausal women);   Drug: Neoadjuvant letrozole (postmenopausal women);   Drug: Neoadjuvant endocrine therapy + palbociclib (if lack of response to endocrine therapy alone);   Drug: Neoadjuvant docetaxel + cyclophosphamide;   Drug: Neoadjuvant docetaxel;   Drug: Neoadjuvant docetaxel + trastuzumab + pertuzumab;   Drug: Neoadjuvant docetaxel + cyclophosphamide + trastuzumab + pertuzumab;   Drug: Neoadjuvant olaparib;   Drug: Neoadjuvant olaparib + carboplatin (if lack of response to olaparib alone);   Procedure: Breast conserving surgery or mastectomy + SNB/axillary dissection;   Radiation: Postoperative radiotherapy breast/chest wall + regional lymph nodes;   Drug: Adjuvant trastuzumab;   Drug: Adjuvant letrozole (postmenopausal women);   Drug: Adjuvant tamoxifen + goserelin (premenopausal women);   Drug: Adjuvant palbociclib (if palbociclib given neoadjuvant);   Drug: Adjuvant Epirubicin+ Cyclophosphamide
16 Completed Breast Cancer With Over-expression of erbB2-BRAINSTORM
Condition: Cancer
Intervention: Drug: Anti-erbB2 therapy as part of a treatment regimen for either brain metastases or primary breast cancer
17 Active, not recruiting Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Condition: Breast Cancer
Interventions: Radiation: Whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy;   Radiation: Higher per daily radiation therapy;   Radiation: Concurrent boost radiotherapy;   Radiation: Standard per daily radiation therapy;   Radiation: Sequential boost radiotherapy
18 Terminated Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Other: Genomic and Proteomic Profiling
19 Terminated Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: methotrexate;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: adjuvant therapy;   Radiation: radiation therapy
20 Active, not recruiting EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies
Condition: Metastatic Cancers
Intervention: Other: Blood sampling

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years